|
Australasian Biotechnology (backfiles)
AusBiotech
ISSN: 1036-7128
Vol. 11, No. 2, 2001, pp. 9-14
|
Bioline Code: au01019
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Australasian Biotechnology (backfiles), Vol. 11, No. 2, 2001, pp. 9-14
en |
BIOTECH BUSINESS
Abstract
ALCHEMIA RAISES $15.2 MILLION
CHEMEQ ENTERS COMMERCIALISATION PHASE
NORWOOD ABBEY ANNOUNCES IMMUNOLOGY BREAKTHROUGH
PATHTECH ACQUIRES BARTELT INSTRUMENTS
PANBIO'S OFFER CLOSES FULLY SUBSCRIBED
PROGEN SET TO EXPAND TECHNOLOGY PLATFORM
BIOTA HOLDINGS
AGEN BLOOD CLOTTING TECHNOLOGY HAS POTENTIAL
GENETIC TECHNOLOGIES' INTERNATIONAL LINK OF SUCCESS
328 PER CENT PROFIT INCREASE FOR AXON INSTRUMENTS
BIOTECH INTERNATIONAL COMPLETES ACQUISITION
METABOLIC PHARMACEUTICALS BEGINS HUMAN TRIALS ON OBESITY DRUG
VACCINE STRATEGY LICENSED FOR THE DEVELOPMENT OF NEW VACCINE
PEREGRINE CORPORATE CONTINUES ITS PUSH INTO BIOTECHNOLOGY
BIOTECH INVESTMENT OFFICER APPOINTED
R&D START GRANT FOR ARTHRITIS RESEARCH
BIOTECH CAPITAL INVESTMENTS
STARPHARMA PROGRESS
STEM CELL GROWTH
NEW NAME FOR EXODUS
PAN MAIDEN PROFIT
BIONOMICS RESULT
SECOND START GRANT FOR VIRAX
FAULDING SELLS SOLTEC
SUMICH PROGRESS ON SILICON TECHNOLOGY
PEOPLE
|
|
© Copyright 2001 - AusBiotech Alternative site location: http://www.ausbiotech.org/content.asp?pageid=16
|
|